Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 121

1.

Immunological Risk Stratification of Bladder Cancer Based on Peripheral Blood Natural Killer Cell Biomarkers.

Guillamón CF, Gimeno L, Server G, Martínez-Sánchez MV, Escudero JF, López-Cubillana P, Cabezas-Herrera J, Campillo JA, Abellan DJ, Martínez-García J, Martínez-Escribano J, Ferri B, López-Álvarez MR, Moreno-Alarcón C, Moya-Quiles MR, Muro M, Minguela A.

Eur Urol Oncol. 2019 May 14. pii: S2588-9311(19)30058-6. doi: 10.1016/j.euo.2019.04.009. [Epub ahead of print]

PMID:
31411976
2.

Activating KIRs on Educated NK Cells Support Downregulation of CD226 and Inefficient Tumor Immunosurveillance.

Guillamón CF, Martínez-Sánchez MV, Gimeno L, Campillo JA, Server-Pastor G, Martínez-García J, Martínez-Escribano J, Torroba A, Ferri B, Abellán DJ, Legaz I, López-Álvarez MR, Moya-Quiles MR, Muro M, Minguela A.

Cancer Immunol Res. 2019 Aug;7(8):1307-1317. doi: 10.1158/2326-6066.CIR-18-0847. Epub 2019 Jun 25.

PMID:
31239317
3.

The role of DOCK10 in the regulation of the transcriptome and aging.

Ruiz-Lafuente N, Minguela A, Muro M, Parrado A.

Heliyon. 2019 Mar 23;5(3):e01391. doi: 10.1016/j.heliyon.2019.e01391. eCollection 2019 Mar.

4.

NKG2D Polymorphism in Melanoma Patients from Southeastern Spain.

Gimeno L, Martínez-Banaclocha H, Bernardo MV, Bolarin JM, Marín L, López-Hernández R, López-Alvarez MR, Moya-Quiles MR, Muro M, Frias-Iniesta JF, Martínez-Escribano J, Alvarez-López MR, Minguela A, Campillo JA.

Cancers (Basel). 2019 Mar 28;11(4). pii: E438. doi: 10.3390/cancers11040438.

5.

T cell senescence predicts subclinical atherosclerosis in HIV-infected patients similarly to traditional cardiovascular risk factors.

Bernal E, Martinez M, Torres A, Guillamón CF, Alcaraz A, Alcaraz MJ, Muñoz A, Valero S, Botella C, Campillo JA, Cano A, Minguela A.

Antiviral Res. 2019 Feb;162:163-170. doi: 10.1016/j.antiviral.2018.12.014. Epub 2018 Dec 26.

PMID:
30593833
6.

The transcriptional response of mouse spleen B cells to IL-4: Comparison to the response of human peripheral blood B cells.

Ruiz-Lafuente N, Muro M, Minguela A, Parrado A.

Biochem Biophys Rep. 2018 Oct 6;16:56-61. doi: 10.1016/j.bbrep.2018.09.007. eCollection 2018 Dec.

7.

NK Cell Education in Tumor Immune Surveillance: DNAM-1/KIR Receptor Ratios as Predictive Biomarkers for Solid Tumor Outcome.

Guillamón CF, Martínez-Sánchez MV, Gimeno L, Mrowiec A, Martínez-García J, Server-Pastor G, Martínez-Escribano J, Torroba A, Ferri B, Abellán D, Campillo JA, Legaz I, López-Álvarez MR, Moya-Quiles MR, Muro M, Minguela A.

Cancer Immunol Res. 2018 Dec;6(12):1537-1547. doi: 10.1158/2326-6066.CIR-18-0022. Epub 2018 Sep 21.

PMID:
30242020
8.

Correction: Increasing TIMP3 expression by hypomethylating agents diminishes soluble MICA, MICB and ULBP2 shedding in acute myeloid leukemia, facilitating NK cell-mediated immune recognition.

Raneros AB, Minguela A, Rodriguez RM, Colado E, Bernal T, Anguita E, Mogorron AV, Gil AC, Vidal-Castiñeira JR, Márquez-Kisinousky L, Bulnes PD, Marin AM, García Garay MC, Suarez-Alvarez B, Lopez-Larrea C.

Oncotarget. 2018 Aug 28;9(67):32881. doi: 10.18632/oncotarget.26079. eCollection 2018 Aug 28.

9.

Patient Sex in the Setting of Liver Transplant in Alcoholic Liver Disease.

Legaz I, Navarro Noguera E, Bolarín JM, Campillo JA, Moya R, Luna A, Miras M, Minguela A, Álvarez-López MR, Muro M.

Exp Clin Transplant. 2019 Jun;17(3):355-362. doi: 10.6002/ect.2017.0302. Epub 2018 Jun 28.

10.

DOCK9 induces membrane ruffles and Rac1 activity in cancer HeLa epithelial cells.

Ruiz-Lafuente N, Minguela A, Parrado A.

Biochem Biophys Rep. 2018 May 22;14:178-181. doi: 10.1016/j.bbrep.2018.05.004. eCollection 2018 Jul.

11.

In vitro intracellular IFNγ, IL-17 and IL-10 producing T cells correlates with the occurrence of post-transplant opportunistic infection in liver and kidney recipients.

Boix F, Llorente S, Eguía J, Gonzalez-Martinez G, Alfaro R, Galián JA, Campillo JA, Moya-Quiles MR, Minguela A, Pons JA, Muro M.

World J Transplant. 2018 Feb 24;8(1):23-37. doi: 10.5500/wjt.v8.i1.23.

12.

Carfilzomib and dexamethasone for extramedullary myeloma with pleuropericardial involvement.

Español I, Romera M, Gutiérrez-Meca MD, García MDC, Tejedor A, Martínez A, Ibáñez J, De Arriba F, Minguela A, Iturbe T, López MD.

Clin Case Rep. 2017 Jun 22;5(8):1258-1260. doi: 10.1002/ccr3.1015. eCollection 2017 Aug.

13.

Increasing TIMP3 expression by hypomethylating agents diminishes soluble MICA, MICB and ULBP2 shedding in acute myeloid leukemia, facilitating NK cell-mediated immune recognition.

Raneros AB, Minguela A, Rodriguez RM, Colado E, Bernal T, Anguita E, Mogorron AV, Gil AC, Vidal-Castiñeira JR, Márquez-Kisinousky L, Bulnes PD, Marin AM, Garay MCG, Suarez-Alvarez B, Lopez-Larrea C.

Oncotarget. 2017 May 9;8(19):31959-31976. doi: 10.18632/oncotarget.16657. Erratum in: Oncotarget. 2018 Aug 28;9(67):32881. Puras, Alfredo Minguela [corrected to Minguela, Alfredo].

14.

CD28 biomarker quantification and expression level profiles in CD4+ T-lymphocytes in solid organ transplantation.

Boix F, Bolarín JM, Mrowiec A, Eguía J, Gonzalez-Martinez G, de la Peña J, Galian JA, Alfaro R, Moya-Quiles MR, Legaz I, Campillo JA, Ramírez P, García-Alonso A, Pons JA, Sánchez-Bueno F, Minguela A, Llorente S, Muro M.

Transpl Immunol. 2017 Jun;42:9-17. doi: 10.1016/j.trim.2017.04.001. Epub 2017 Apr 6.

PMID:
28392336
15.

The Effect of Regular Intake of Dry-Cured Ham Rich in Bioactive Peptides on Inflammation, Platelet and Monocyte Activation Markers in Humans.

Martínez-Sánchez SM, Minguela A, Prieto-Merino D, Zafrilla-Rentero MP, Abellán-Alemán J, Montoro-García S.

Nutrients. 2017 Mar 23;9(4). pii: E321. doi: 10.3390/nu9040321.

16.

Pretransplant CD28 Biomarker (Levels of Expression and Quantification of Molecules per Cell) in Peripheral CD4+ T Cells Predicts Acute Rejection Episodes in Liver and Kidney Recipients.

Boix F, Bolarín JM, Eguía J, Gonzalez-Martinez G, De La Peña J, Galian JA, Hernández-Martínez AM, Moya-Quiles MR, Legaz I, Campillo JA, Ramirez P, Sanchez-Bueno F, García-Alonso AM, Pons JA, Minguela A, Llorente S, Muro M.

Transplant Proc. 2016 Nov;48(9):2987-2989. doi: 10.1016/j.transproceed.2016.09.028.

PMID:
27932126
17.

Killer immunoglobulin-like receptor repertoire analysis in a Caucasian Spanish cohort with inflammatory bowel disease.

López-Hernández R, Campillo JA, Legaz I, Valdés M, Salama H, Boix F, Hernández-Martínez AM, Eguia J, González-Martínez G, Moya-Quiles MR, Minguela A, García-Alonso A, Carballo F, Muro M.

Microbiol Immunol. 2016 Nov;60(11):787-792. doi: 10.1111/1348-0421.12447.

18.

Dock10 regulates CD23 expression and sustains B-cell lymphopoiesis in secondary lymphoid tissue.

García-Serna AM, Alcaraz-García MJ, Ruiz-Lafuente N, Sebastián-Ruiz S, Martínez CM, Moya-Quiles MR, Minguela A, García-Alonso AM, Martín-Orozco E, Parrado A.

Immunobiology. 2016 Dec;221(12):1343-1350. doi: 10.1016/j.imbio.2016.07.015. Epub 2016 Aug 2.

PMID:
27502165
19.

Diagnostic screening of paroxysmal nocturnal hemoglobinuria: Prospective multicentric evaluation of the current medical indications.

Morado M, Freire Sandes A, Colado E, Subirá D, Isusi P, Soledad Noya M, Belén Vidriales M, Sempere A, Ángel Díaz J, Minguela A, Álvarez B, Serrano C, Caballero T, Rey M, Pérez Corral A, Cristina Fernández Jiménez M, Magro E, Lemes A, Benavente C, Bañas H, Merino J, Castejon C, Gutierrez O, Rabasa P, Vescosi Gonçalves M, Perez-Andres M, Orfao A; PNH working group of the Iberian Society of Cytometry (SIC).

Cytometry B Clin Cytom. 2017 Sep;92(5):361-370. doi: 10.1002/cyto.b.21480. Epub 2016 Oct 1.

20.

Circulating aberrant plasma cells allows risk stratification of patients with myeloma.

Periago A, Campillo JA, Mrowiec A, Gimeno L, Montes NR, Martínez-Sánchez MV, Cabañas-Perianes V, García-Garay C, Bolarin JM, Blasco-Mogorrón A, Muro M, Berenguer M, Moraleda JM, García-Alonso AM, Minguela A.

Am J Hematol. 2016 Sep;91(9):E353-E355. doi: 10.1002/ajh.24431. Epub 2016 May 24. No abstract available.

21.

Overexpression of KIR inhibitory ligands (HLA-I) determines that immunosurveillance of myeloma depends on diverse and strong NK cell licensing.

Martínez-Sánchez MV, Periago A, Legaz I, Gimeno L, Mrowiec A, Montes-Barqueros NR, Campillo JA, Bolarin JM, Bernardo MV, López-Álvarez MR, González C, García-Garay MC, Muro M, Cabañas-Perianes V, Fuster JL, García-Alonso AM, Moraleda JM, Álvarez-Lopez MR, Minguela A.

Oncoimmunology. 2015 Oct 29;5(4):e1093721. eCollection 2016 Apr.

22.

High expression of CD38, CD69, CD95 and CD154 biomarkers in cultured peripheral T lymphocytes correlates with an increased risk of acute rejection in liver allograft recipients.

Boix F, Millan O, San Segundo D, Mancebo E, Rimola A, Fabrega E, Fortuna V, Mrowiec A, Castro-Panete MJ, Peña Jde L, Llorente S, Minguela A, Bolarin JM, Paz-Artal E, Lopez-Hoyos M, Brunet M, Muro M.

Immunobiology. 2016 May;221(5):595-603. doi: 10.1016/j.imbio.2016.01.008. Epub 2016 Jan 25.

PMID:
26850323
23.

Comparison of Two Types of Liquid Biopsies in Patients With Hepatocellular Carcinoma Awaiting Orthotopic Liver Transplantation.

Sánchez-Lorencio MI, Ramirez P, Saenz L, Martínez Sánchez MV, De La Orden V, Mediero-Valeros B, Veganzones-De-Castro S, Baroja-Mazo A, Revilla Nuin B, Gonzalez MR, Cascales-Campos PA, Noguera-Velasco JA, Minguela A, Díaz-Rubio E, Pons JA, Parrilla P.

Transplant Proc. 2015 Nov;47(9):2639-42. doi: 10.1016/j.transproceed.2015.10.003.

PMID:
26680058
24.

Activated Regulatory T Cells Expressing CD4(+)CD25(high)CD45RO(+)CD62L(+) Biomarkers Could Be a Risk Factor in Liver Allograft Rejection.

Boix F, Millan O, San Segundo D, Mancebo E, Miras M, Rimola A, Fábrega E, Allende L, Minguela A, Paz-Artal E, López-Hoyos M, Brunet M, Muro M.

Transplant Proc. 2015 Oct;47(8):2380-1. doi: 10.1016/j.transproceed.2015.09.007.

PMID:
26518933
25.

High frequency of central memory regulatory T cells allows detection of liver recipients at risk of early acute rejection within the first month after transplantation.

Boix-Giner F, Millan O, San Segundo D, Muñoz-Cacho P, Mancebo E, Llorente S, Rafael-Valdivia L, Rimola A, Fábrega E, Mrowiec A, Allende L, Minguela A, Bolarín JM, Paz-Artal E, López-Hoyos M, Brunet M, Muro M.

Int Immunol. 2016 Feb;28(2):55-64. doi: 10.1093/intimm/dxv048. Epub 2015 Aug 12.

26.

IL-4 Up-Regulates MiR-21 and the MiRNAs Hosted in the CLCN5 Gene in Chronic Lymphocytic Leukemia.

Ruiz-Lafuente N, Alcaraz-García MJ, Sebastián-Ruiz S, García-Serna AM, Gómez-Espuch J, Moraleda JM, Minguela A, García-Alonso AM, Parrado A.

PLoS One. 2015 Apr 24;10(4):e0124936. doi: 10.1371/journal.pone.0124936. eCollection 2015.

27.

MHC class I chain-related gene a diversity in patients with cutaneous malignant melanoma from southeastern Spain.

Campillo JA, López-Hernández R, Martínez-Banaclocha H, Bolarín JM, Gimeno L, Mrowiec A, López M, Las Heras B, Minguela A, Moya-Quiles MR, Legáz I, Frías-Iniesta JF, García-Alonso AM, Álvarez-López MR, Martínez-Escribano JA, Muro M.

Dis Markers. 2015;2015:831864. doi: 10.1155/2015/831864. Epub 2015 Mar 9.

28.

Pro- and anti-inflammatory cytokine gene single-nucleotide polymorphisms in inflammatory bowel disease.

López-Hernández R, Valdés M, Campillo JA, Martínez-García P, Salama H, Bolarin JM, Martínez H, Moya-Quiles MR, Minguela A, Sánchez-Torres A, Botella C, Salgado G, Miras M, Carballo F, Muro M.

Int J Immunogenet. 2015 Feb;42(1):38-45. doi: 10.1111/iji.12160. Epub 2014 Oct 31.

PMID:
25359546
29.

The gene expression response of chronic lymphocytic leukemia cells to IL-4 is specific, depends on ZAP-70 status and is differentially affected by an NFκB inhibitor.

Ruiz-Lafuente N, Alcaraz-García MJ, Sebastián-Ruiz S, Gómez-Espuch J, Funes C, Moraleda JM, García-Garay MC, Montes-Barqueros N, Minguela A, Álvarez-López MR, Parrado A.

PLoS One. 2014 Oct 3;9(10):e109533. doi: 10.1371/journal.pone.0109533. eCollection 2014.

30.

Donor specific antibodies median fluorescence intensity levels are the best indicator for monitoring desensitization treatment in kidney transplant.

Boix F, Llorente S, Mrowiec A, Eguia J, López-Hernández R, Bernardo MV, Moya-Quiles MR, Campillo JA, Minguela A, Jimeno L, Alvarez-López MR, Muro M.

Urol J. 2014 Jul 8;11(3):1695-8. No abstract available.

31.

HLA-C antibodies are associated with irreversible rejection in kidney transplantation: Shared molecular eplets characterization.

Bosch A, Llorente S, Eguia J, Mrowiec A, Boix F, López-Hernández R, Campillo JA, Salgado G, Moya-Quiles MR, Minguela A, Jimeno L, Alvarez-López MR, Muro M.

Hum Immunol. 2014 Apr;75(4):338-41. doi: 10.1016/j.humimm.2014.01.010. Epub 2014 Jan 30.

PMID:
24486575
32.

Severe combined immunodeficiency: first report of a de novo mutation in the IL2RG gene in a boy conceived by in vitro fertilization.

Moya-Quiles MR, Bernardo-Pisa MV, Menasalvas A, Alfayate S, Fuster JL, Boix F, Salgado G, Muro M, Minguela A, Alvarez-López MR, García-Alonso AM.

Clin Genet. 2014 May;85(5):500-1. doi: 10.1111/cge.12208. Epub 2013 Jun 24. No abstract available.

PMID:
23790094
33.

Genetic polymorphisms of tumour necrosis factor alpha (TNF-α) promoter gene and response to TNF-α inhibitors in Spanish patients with inflammatory bowel disease.

López-Hernández R, Valdés M, Campillo JA, Martínez-Garcia P, Salama H, Salgado G, Boix F, Moya-Quiles MR, Minguela A, Sánchez-Torres A, Miras M, Garcia A, Carballo F, Álvarez-López MR, Muro M.

Int J Immunogenet. 2014 Feb;41(1):63-8. doi: 10.1111/iji.12059. Epub 2013 Apr 17.

PMID:
23590430
34.

Imaging cytometry for counting circulating tumor cells: comparative analysis of the CellSearch vs ImageStream systems.

López-Riquelme N, Minguela A, Villar-Permuy F, Ciprian D, Castillejo A, Álvarez-López MR, Soto JL.

APMIS. 2013 Dec;121(12):1139-43. doi: 10.1111/apm.12061. Epub 2013 Mar 20.

PMID:
23510386
35.

KIR gene mismatching and KIR/C ligands in liver transplantation: consequences for short-term liver allograft injury.

Legaz I, López-Álvarez MR, Campillo JA, Moya-Quiles MR, Bolarín JM, de la Peña J, Salgado G, Gimeno L, García-Alonso AM, Muro M, Miras M, Alonso C, Álvarez-López MR, Minguela A.

Transplantation. 2013 Apr 27;95(8):1037-44. doi: 10.1097/TP.0b013e318286486c.

PMID:
23478359
36.

KIR gene variability in cutaneous malignant melanoma: influence of KIR2D/HLA-C pairings on disease susceptibility and prognosis.

Campillo JA, Legaz I, López-Álvarez MR, Bolarín JM, Las Heras B, Muro M, Minguela A, Moya-Quiles MR, Blanco-García R, Martínez-Banaclocha H, García-Alonso AM, Alvarez-López MR, Martínez-Escribano JA.

Immunogenetics. 2013 May;65(5):333-43. doi: 10.1007/s00251-013-0682-0. Epub 2013 Jan 31.

PMID:
23370861
37.

HLA-DRB1 and HLA-DQB1 genes on susceptibility to and protection from allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.

Muro M, Mondejar-López P, Moya-Quiles MR, Salgado G, Pastor-Vivero MD, Lopez-Hernandez R, Boix F, Campillo JA, Minguela A, Garcia-Alonso A, Sánchez-Solís M, Álvarez-López MR.

Microbiol Immunol. 2013 Mar;57(3):193-7. doi: 10.1111/1348-0421.12020.

38.

Post-transplant increase in soluble human leukocyte antigen-G associated with non-severe cardiac allograft vasculopathy.

Blanco-García RM, López-Álvarez MR, Garrido IP, Salgado-Cecilia G, Campillo JA, Bolarín JM, Gimeno L, Muro M, García-Alonso AM, Martínez-Sánchez MV, Bernardo Pisa MV, Soriano-Díaz S, Pascual-Figal DA, Alvarez-López MR, Minguela A.

Hum Immunol. 2013 Mar;74(3):318-24. doi: 10.1016/j.humimm.2012.12.001. Epub 2012 Dec 14.

PMID:
23247208
39.

C1q-fixing human leukocyte antigen assay in immunized renal patients: correlation between Luminex SAB-C1q and SAB-IgG.

Llorente S, Boix F, Eguia J, López M, Bosch A, Martinez H, Gonzalez MJ, López-Hernández R, Salgado G, Moya-Quiles MR, Campillo JA, García-Alonso AM, Minguela A, Jimeno L, Alvarez-López MR, Muro M.

Transplant Proc. 2012 Nov;44(9):2535-7. doi: 10.1016/j.transproceed.2012.09.084.

PMID:
23146446
40.

Low median fluorescence intensity could be a nonsafety concept of immunologic risk evaluation in patients with shared molecular eplets in kidney transplantation.

Bosch A, Llorente S, Diaz JA, Salgado G, López M, Boix F, López-Hernández R, González-Soriano MJ, Campillo JA, Moya-Quiles MR, Perez-Lopez N, Minguela A, Jimeno L, Alvarez-López MR, Muro M.

Hum Immunol. 2012 May;73(5):522-5. doi: 10.1016/j.humimm.2012.02.020. Epub 2012 Mar 6.

PMID:
22425738
41.

Evolution of soluble forms of CD86, CD95 and CD95L molecules in liver transplant recipients.

Marín LA, Moya-Quiles MR, Miras M, Minguela A, Bermejo J, Ramírez P, García-Alonso AM, Parrilla P, Alvarez-López MR, Muro M.

Transpl Immunol. 2012 Mar;26(2-3):94-100. doi: 10.1016/j.trim.2011.12.001. Epub 2011 Dec 13.

PMID:
22182632
42.

Influence of human leukocyte antigen mismatching on rejection development and allograft survival in liver transplantation: is the relevance of HLA-A locus matching being underestimated?

Muro M, López-Álvarez MR, Campillo JA, Marin L, Moya-Quiles MR, Bolarín JM, Botella C, Salgado G, Martínez P, Sánchez-Bueno F, López-Hernández R, Boix F, Bosch A, Martínez H, de la Peña-Moral JM, Pérez N, Robles R, García-Alonso AM, Minguela A, Miras M, Alvarez-López MR.

Transpl Immunol. 2012 Mar;26(2-3):88-93. doi: 10.1016/j.trim.2011.11.006. Epub 2011 Nov 23.

PMID:
22129495
43.

Soluble ST2 is a marker for acute cardiac allograft rejection.

Pascual-Figal DA, Garrido IP, Blanco R, Minguela A, Lax A, Ordoñez-Llanos J, Bayes-Genis A, Valdés M, Moore SA, Januzzi JL.

Ann Thorac Surg. 2011 Dec;92(6):2118-24. doi: 10.1016/j.athoracsur.2011.07.048. Epub 2011 Oct 28.

PMID:
22035779
44.

[Usefulness of high sensitivity troponin T assay in detecting acute allograft rejection after heart transplantation].

Muñoz-Esparza C, Garrido IP, Blanco R, Casas T, González-Cánovas C, Pastor-Pérez F, Peñafiel P, Minguela A, Valdés M, Pascual-Figal DA.

Rev Esp Cardiol. 2011 Dec;64(12):1109-13. doi: 10.1016/j.recesp.2011.06.017. Epub 2011 Sep 15. Spanish.

45.

CD28 and KIR2D receptors as sensors of the immune status in heart and liver transplantation.

Blanco-García RM, López-Álvarez MR, Garrido IP, Salgado-Cecilia G, Campillo JA, Bolarín JM, Legaz I, Muro M, García-Alonso AM, Martínez-Sánchez MV, Moral JM, Pascual-Figal DA, Alvarez-López MR, Miras M, Minguela A.

Hum Immunol. 2011 Oct;72(10):841-8. doi: 10.1016/j.humimm.2011.06.004. Epub 2011 Jun 22.

PMID:
21742001
46.

Divergences in KIR2D+ natural killer and KIR2D+CD8+ T-cell reconstitution following liver transplantation.

López-Álvarez MR, Campillo JA, Legaz I, Blanco-García RM, Salgado-Cecilia G, Bolarín JM, Gimeno L, Gil J, García-Alonso AM, Muro M, Alvarez-López MR, Miras M, Minguela A.

Hum Immunol. 2011 Mar;72(3):229-37. doi: 10.1016/j.humimm.2010.12.015. Epub 2011 Jan 4.

PMID:
21215286
47.

Cryopreservation impact on blood progenitor cells: influence of diagnoses, mobilization treatments, and cell concentration.

Majado MJ, Salgado-Cecilia G, Blanquer M, Funes C, González-García C, Insausti CL, Parrado A, Morales A, Minguela A, Moraleda JM.

Transfusion. 2011 Apr;51(4):799-807. doi: 10.1111/j.1537-2995.2010.02885.x. Epub 2010 Sep 28.

PMID:
20880003
48.

Specific "intra-allele" and "intra-broad antigen" human leukocyte antigen alloantibodies in kidney graft transplantation.

Muro M, González-Soriano MJ, Salgado G, López R, Boix F, López M, Campillo JA, Martínez P, Botella C, Gimeno L, Minguela A, Alvarez-López MR, Llorente S.

Hum Immunol. 2010 Sep;71(9):857-60. doi: 10.1016/j.humimm.2010.05.018. Epub 2010 May 25.

PMID:
20510320
49.

Association analysis of MICA gene polymorphism and MICA-129 dimorphism with inflammatory bowel disease susceptibility in a Spanish population.

López-Hernández R, Valdés M, Lucas D, Campillo JA, Martínez-Garcia P, Salama H, López M, Salgado G, Botella C, Minguela A, Miras M, Alvarez-López MR, Carballo F, Muro M.

Hum Immunol. 2010 May;71(5):512-4. doi: 10.1016/j.humimm.2010.02.003. Epub 2010 Mar 4.

PMID:
20152875
50.

HLA-C matching and liver transplants: donor-recipient genotypes influence early outcome and CD8+KIR2D+ T-cells recuperation.

López-Alvarez MR, Moya-Quiles MR, Minguela A, Gil J, Miras M, Campillo JA, Díaz-Alderete MA, García-Alonso AM, Sánchez-Bueno F, Vicario JL, Muro M, Alvarez-López MR.

Transplantation. 2009 Aug 15;88(3 Suppl):S54-61. doi: 10.1097/TP.0b013e3181af7d84.

PMID:
19667963

Supplemental Content

Loading ...
Support Center